Maintenance Therapy With Subcutaneous Bortezomib

Clinical trial NCT01913730 · COMPLETED

Trial details

NCT number: NCT01913730
Sponsor: European Myeloma Network B.V.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2013-11-01
Primary completion: 2021-04-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.